BidaskClub cut shares of Mazor Robotics (NASDAQ:MZOR) from a strong-buy rating to a buy rating in a report issued on Saturday morning.
MZOR has been the subject of a number of other reports. Barclays restated a hold rating and set a $34.00 price target on shares of Mazor Robotics in a research note on Wednesday, October 11th. Zacks Investment Research downgraded Mazor Robotics from a hold rating to a sell rating in a research note on Thursday, November 9th. Needham & Company LLC reiterated a hold rating on shares of Mazor Robotics in a research note on Tuesday, November 7th. Ladenburg Thalmann Financial Services set a $67.00 price objective on Mazor Robotics and gave the company a buy rating in a research note on Monday, October 30th. Finally, TheStreet upgraded Mazor Robotics from a d rating to a c- rating in a research note on Wednesday, November 8th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company’s stock. Mazor Robotics presently has an average rating of Hold and an average price target of $39.83.
Mazor Robotics (MZOR) traded down $0.32 during trading on Friday, hitting $57.83. The company’s stock had a trading volume of 310,115 shares, compared to its average volume of 547,292. Mazor Robotics has a 1-year low of $20.50 and a 1-year high of $65.97.
Several large investors have recently made changes to their positions in MZOR. Gilder Gagnon Howe & Co. LLC bought a new position in shares of Mazor Robotics during the 2nd quarter valued at approximately $8,014,000. Sumitomo Mitsui Trust Holdings Inc. bought a new position in Mazor Robotics in the 3rd quarter worth approximately $6,371,000. Global X MANAGEMENT CO LLC boosted its stake in Mazor Robotics by 5,758.8% in the 3rd quarter. Global X MANAGEMENT CO LLC now owns 115,536 shares of the medical instruments supplier’s stock worth $5,704,000 after purchasing an additional 113,564 shares during the period. Crawford Lake Capital Management LLC bought a new position in Mazor Robotics in the 3rd quarter worth approximately $4,554,000. Finally, Dorsey Wright & Associates bought a new position in Mazor Robotics in the 3rd quarter worth approximately $4,537,000. Institutional investors own 26.46% of the company’s stock.
About Mazor Robotics
Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.